Literature DB >> 34091712

Bioanalytical methods for circulating extracellular matrix-related proteins: new opportunities in cancer diagnosis.

Ramón Lorenzo-Gómez1,2, Rebeca Miranda-Castro1,2, Noemí de-Los-Santos-Álvarez1,2, María Jesús Lobo-Castañón3,4.   

Abstract

The role of the extracellular matrix (ECM) remodeling in tumorigenesis and metastasis is becoming increasingly clear. Cancer development requires that tumor cells recruit a tumor microenvironment permissive for further tumor growth. This is a dynamic process that takes place by a cross-talk between tumor cells and ECM. As a consequence, molecules derived from the ECM changes associated to cancer are released into the bloodstream, representing potential biomarkers of tumor development. This article highlights the importance of developing and improving bioanalytical methods for the detection of ECM remodeling-derived components, as a step forward to translate the basic knowledge about cancer progression into the clinical practice.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Aptamer-based assays; Circulating cancer biomarkers; Extracellular matrix; Immunoassays

Mesh:

Substances:

Year:  2021        PMID: 34091712     DOI: 10.1007/s00216-021-03416-2

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  59 in total

Review 1.  Extracellular matrix structure.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Chrysostomi Gialeli; Nikos K Karamanos
Journal:  Adv Drug Deliv Rev       Date:  2015-11-10       Impact factor: 15.470

2.  A graphene oxide-based FRET sensor for rapid and sensitive detection of matrix metalloproteinase 2 in human serum sample.

Authors:  Erqun Song; Dan Cheng; Yang Song; Mingdong Jiang; Jifei Yu; Yunyun Wang
Journal:  Biosens Bioelectron       Date:  2013-03-21       Impact factor: 10.618

Review 3.  The extracellular matrix modulates the hallmarks of cancer.

Authors:  Michael W Pickup; Janna K Mouw; Valerie M Weaver
Journal:  EMBO Rep       Date:  2014-11-08       Impact factor: 8.807

Review 4.  Emerging roles of proteases in tumour suppression.

Authors:  Carlos López-Otín; Lynn M Matrisian
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

Review 5.  Tumor stroma derived biomarkers in cancer.

Authors:  Malin Sund; Raghu Kalluri
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

Review 6.  The rationale for targeting the LOX family in cancer.

Authors:  Holly E Barker; Thomas R Cox; Janine T Erler
Journal:  Nat Rev Cancer       Date:  2012-07-19       Impact factor: 60.716

Review 7.  The extracellular matrix: Tools and insights for the "omics" era.

Authors:  Alexandra Naba; Karl R Clauser; Huiming Ding; Charles A Whittaker; Steven A Carr; Richard O Hynes
Journal:  Matrix Biol       Date:  2015-07-08       Impact factor: 11.583

8.  The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.

Authors:  Alexandra Naba; Karl R Clauser; Sebastian Hoersch; Hui Liu; Steven A Carr; Richard O Hynes
Journal:  Mol Cell Proteomics       Date:  2011-12-09       Impact factor: 5.911

Review 9.  Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression.

Authors:  Sylvie Brassart-Pasco; Stéphane Brézillon; Bertrand Brassart; Laurent Ramont; Jean-Baptiste Oudart; Jean Claude Monboisse
Journal:  Front Oncol       Date:  2020-04-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.